Heparin interferes with measurement of aminoglycosides in serum by biological, radioenzymatic, and homogeneous enzyme immunoassay techniques, but not with radioimmunoassay. At concentrations ≥ 105 and ≥ 3 X 106 USP units/L, respectively, it interferes with the radioenzymatic assay by inhibiting the gentamicin 3-acetyltransferase (EC 2.3.1.60) and kanamycin 6'-acetyltransferase (EC 2.3.1.55) enzymes used in the assay. It interferes with the homogeneous enzyme immunoassays for gentamicin and tobramycin (at concentrations ≥ 105 and ≥ 104 USP units/L, respectively), but not with the commercially available homogeneous enzyme immunoassays for other drugs. Heparin interference with the homogeneous enzyme immunoassay for aminoglycosides requires both the heparin polyanion and glucose-6-phosphate dehydrogenase (EC 1.1.1.49) bound to a cationic aminoglycoside. This interference can be reproduced with dextran sulfate (but not dextran), and does not occur with free enzyme (glucose-6-phosphate dehydrogenase) alone. We describe how heparin interferes with these two assays and demonstrate interference at heparin concentrations that may be present in intravenous infusions or in seriously underfilled blood-collection tubes.
CITATION STYLE
Krogstad, D. J., Granich, G. G., Murray, P. R., Pfaller, M. A., & Valdes, R. (1982). Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassays for aminoglycosides. Clinical Chemistry, 28(7), 1517–1521. https://doi.org/10.1093/clinchem/28.7.1517
Mendeley helps you to discover research relevant for your work.